News

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...
In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatmentCombination of oral PL7737 ...
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment Combination of oral PL7737 and tirzepatide resulted in additive ...
Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% total body weight lost.